Cohort study reveals distinct microbial changes in cirrhosis with hepatocellular carcinoma, indicating implications for liver disease progression.
Among the Thai cohort, HCC with cirrhosis was associated with distinct gut microbial changes, reduced BCoAT expression, increased gut permeability, and cytokine alterations, highlighting the contribution of gut dysbiosis and microbial by-products to liver disease progression.
No takes yet. Share an insight, caveat, or question.
Jinato et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: